Teladoc Health Inc (TDOC) Expected to Post Earnings of -$0.36 Per Share

Share on StockTwits

Wall Street analysts forecast that Teladoc Health Inc (NYSE:TDOC) will announce earnings per share of ($0.36) for the current quarter, according to Zacks Investment Research. Eleven analysts have made estimates for Teladoc Health’s earnings, with the highest EPS estimate coming in at ($0.33) and the lowest estimate coming in at ($0.41). Teladoc Health posted earnings per share of ($0.55) during the same quarter last year, which indicates a positive year over year growth rate of 34.5%. The business is expected to announce its next quarterly earnings results after the market closes on Thursday, November 1st.

On average, analysts expect that Teladoc Health will report full year earnings of ($1.49) per share for the current financial year, with EPS estimates ranging from ($1.57) to ($1.42). For the next fiscal year, analysts expect that the company will report earnings of ($1.10) per share, with EPS estimates ranging from ($1.56) to ($0.29). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research analysts that follow Teladoc Health.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, August 1st. The health services provider reported ($0.37) EPS for the quarter, beating the consensus estimate of ($0.38) by $0.01. Teladoc Health had a negative net margin of 37.78% and a negative return on equity of 19.10%. The company had revenue of $94.60 million for the quarter, compared to the consensus estimate of $91.56 million. During the same period in the prior year, the firm posted ($0.28) EPS. The firm’s revenue was up 112.1% compared to the same quarter last year.

Several analysts have recently issued reports on TDOC shares. Chardan Capital lifted their target price on shares of Teladoc Health from $73.00 to $86.00 and gave the company a “buy” rating in a research report on Friday, August 3rd. Berenberg Bank initiated coverage on shares of Teladoc Health in a research report on Monday, July 9th. They set a “buy” rating and a $72.00 price target for the company. Canaccord Genuity reissued a “buy” rating and set a $70.00 price target (up previously from $63.00) on shares of Teladoc Health in a research report on Wednesday, July 25th. Citigroup lifted their price objective on shares of Teladoc Health to $80.00 and gave the stock a “buy” rating in a report on Thursday, July 19th. Finally, Jefferies Financial Group set a $74.00 price objective on shares of Teladoc Health and gave the stock a “buy” rating in a report on Wednesday, July 11th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. Teladoc Health currently has an average rating of “Buy” and a consensus target price of $81.95.

Shares of NYSE:TDOC traded down $1.14 during midday trading on Tuesday, reaching $67.09. The company’s stock had a trading volume of 837,518 shares, compared to its average volume of 2,091,957. Teladoc Health has a twelve month low of $27.30 and a twelve month high of $89.05. The company has a current ratio of 3.14, a quick ratio of 3.14 and a debt-to-equity ratio of 0.58.

In other news, VP Mark Hirschhorn sold 35,000 shares of the stock in a transaction on Tuesday, September 25th. The stock was sold at an average price of $80.42, for a total transaction of $2,814,700.00. Following the sale, the vice president now owns 10,000 shares in the company, valued at $804,200. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Adam C. Vandervoort sold 5,549 shares of the stock in a transaction on Wednesday, August 8th. The stock was sold at an average price of $67.25, for a total value of $373,170.25. Following the sale, the insider now owns 2,934 shares in the company, valued at approximately $197,311.50. The disclosure for this sale can be found here. Insiders sold 156,706 shares of company stock worth $11,710,929 over the last quarter. Company insiders own 3.95% of the company’s stock.

Several hedge funds have recently made changes to their positions in TDOC. Garner Asset Management Corp bought a new stake in shares of Teladoc Health during the second quarter worth $200,000. Pier 88 Investment Partners LLC bought a new stake in shares of Teladoc Health during the second quarter worth $201,000. Aperio Group LLC bought a new stake in shares of Teladoc Health during the second quarter worth $201,000. California Public Employees Retirement System bought a new stake in shares of Teladoc Health during the second quarter worth $203,000. Finally, Biondo Investment Advisors LLC bought a new stake in shares of Teladoc Health during the second quarter worth $205,000.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: What is dollar cost averaging (DCA)?

Get a free copy of the Zacks research report on Teladoc Health (TDOC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply